Shopping Cart 0
Cart Subtotal
USD 0

Abiomed Inc (ABMD) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company's heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc (ABMD)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Abiomed Inc, Medical Equipment, Deal Details 11

Venture Financing 11

Reprieve Cardiovascular Raises USD7 Million in Venture Financing 11

Magenta Medical Raises USD15 Million in Series B Financing 12

ALung Technologies Raises Funds through Series C Financing 13

Partnerships 15

Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 15

Acquisition 16

Abiomed Acquires ECP from Syscore for USD13 Million 16

Abiomed Inc-Key Competitors 17

Abiomed Inc-Key Employees 18

Abiomed Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Strategy And Business Planning 20

Mar 30, 2017: Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts 20

Financial Announcements 21

Jul 26, 2018: Abiomed announces Q1 FY 2019 record revenue of USD 180 million, Up 36% over prior year 21

May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of USD 174 Million, Up 40%, and Total Year Revenue of USD 594 Million, Up 33%, Over Prior Year 22

Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of USD 154 Million, Up 34% Over Prior Year 23

Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of USD 154M, Up 34% Over Prior Year 24

Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of USD 132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 25

Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of USD 132.5 Million, Up 29% Over Prior Year 26

May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of USD 124.7 Million, Up 33% Over Prior Year and Total Year Revenue of USD 445.3 Million, Up 35% Over Prior Year 28

Jan 26, 2017: Abiomed Announces Q3 FY 2017 Revenue of USD 114.7 Million, Up 34% Over Prior Year 29

Jan 09, 2017: Abiomed Announces Preliminary Q3 FY 2017 Revenue of USD 114.7 Million, Up 34% Over Prior Year 30

Corporate Communications 31

Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 31

Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 32

Product News 33

Sep 24, 2018: Data presented at TCT 2018 shows use of Impella and best practices increases cardiogenic shock survival 33

Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations 34

Oct 19, 2017: Abiomed's Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations 35

Jun 09, 2017: Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology 36

Mar 19, 2017: First-Ever Presentation on Abiomed's Impella Quality Assurance Program at the 2017 American College of Cardiology Scientific Session 37

Mar 16, 2017: Abiomed's Impella Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations 39

Other Significant Developments 41

Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery 41

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Abiomed Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Abiomed Inc, Medical Equipment, Key Facts, 2018 2

Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Abiomed Inc, Deals By Market, 2012 to YTD 2018 9

Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Reprieve Cardiovascular Raises USD7 Million in Venture Financing 11

Magenta Medical Raises USD15 Million in Series B Financing 12

ALung Technologies Raises Funds through Series C Financing 13

Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 15

Abiomed Acquires ECP from Syscore for USD13 Million 16

Abiomed Inc, Key Competitors 17

Abiomed Inc, Key Employees 18

Abiomed Inc, Subsidiaries 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Abiomed Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company's heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc (ABMD)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Abiomed Inc, Medical Equipment, Deal Details 11

Venture Financing 11

Reprieve Cardiovascular Raises USD7 Million in Venture Financing 11

Magenta Medical Raises USD15 Million in Series B Financing 12

ALung Technologies Raises Funds through Series C Financing 13

Partnerships 15

Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 15

Acquisition 16

Abiomed Acquires ECP from Syscore for USD13 Million 16

Abiomed Inc-Key Competitors 17

Abiomed Inc-Key Employees 18

Abiomed Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Strategy And Business Planning 20

Mar 30, 2017: Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts 20

Financial Announcements 21

Jul 26, 2018: Abiomed announces Q1 FY 2019 record revenue of USD 180 million, Up 36% over prior year 21

May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of USD 174 Million, Up 40%, and Total Year Revenue of USD 594 Million, Up 33%, Over Prior Year 22

Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of USD 154 Million, Up 34% Over Prior Year 23

Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of USD 154M, Up 34% Over Prior Year 24

Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of USD 132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 25

Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of USD 132.5 Million, Up 29% Over Prior Year 26

May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of USD 124.7 Million, Up 33% Over Prior Year and Total Year Revenue of USD 445.3 Million, Up 35% Over Prior Year 28

Jan 26, 2017: Abiomed Announces Q3 FY 2017 Revenue of USD 114.7 Million, Up 34% Over Prior Year 29

Jan 09, 2017: Abiomed Announces Preliminary Q3 FY 2017 Revenue of USD 114.7 Million, Up 34% Over Prior Year 30

Corporate Communications 31

Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 31

Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 32

Product News 33

Sep 24, 2018: Data presented at TCT 2018 shows use of Impella and best practices increases cardiogenic shock survival 33

Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations 34

Oct 19, 2017: Abiomed's Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations 35

Jun 09, 2017: Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology 36

Mar 19, 2017: First-Ever Presentation on Abiomed's Impella Quality Assurance Program at the 2017 American College of Cardiology Scientific Session 37

Mar 16, 2017: Abiomed's Impella Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations 39

Other Significant Developments 41

Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery 41

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Abiomed Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Abiomed Inc, Medical Equipment, Key Facts, 2018 2

Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Abiomed Inc, Deals By Market, 2012 to YTD 2018 9

Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Reprieve Cardiovascular Raises USD7 Million in Venture Financing 11

Magenta Medical Raises USD15 Million in Series B Financing 12

ALung Technologies Raises Funds through Series C Financing 13

Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 15

Abiomed Acquires ECP from Syscore for USD13 Million 16

Abiomed Inc, Key Competitors 17

Abiomed Inc, Key Employees 18

Abiomed Inc, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Abiomed Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat